Patents by Inventor Bernard A. Connolly

Bernard A. Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8557554
    Abstract: The present invention relates to a variant archaeal DNA polymerase having a modified amino acid sequence of a wild-type amino acid sequence, the modified sequence being in the amino-terminal amino acids that comprise a uracil-binding pocket in the wild-type polymerase whereby the variant polymerase has reduced affinity for uracil than the wild-type polymerase. Such variant polymerases may be usefully employed in biological assay systems such as the polymerase chain reaction.
    Type: Grant
    Filed: April 15, 2003
    Date of Patent: October 15, 2013
    Assignee: The University of Newcastle
    Inventors: Bernard Connolly, Mark Fogg, Laurence H Pearl
  • Publication number: 20070269877
    Abstract: The present invention relates to a variant archaeal DNA polymerase comprising a modified amino acid sequence of a wild-type amino acid sequence, wherein during DNA replication, the variant polymerase is adapted to mis-incorporate a greater number of incorrect bases than compared to a wild-type archaeal DNA polymerase. Such a variant DNA polymerase may be usefully employed in biological assay systems, such as PCR.
    Type: Application
    Filed: August 26, 2005
    Publication date: November 22, 2007
    Applicant: The University of Newcastle
    Inventors: Bernard Connolly, Ben Biles
  • Publication number: 20060057682
    Abstract: The present invention relates to a variant archaeal DNA polymerase having a modified amino acid sequence of a wild-type amino acid sequence, the modified sequence being in the amino-terminal amino acids that comprise a uracil-binding pocket in the wild-type polymerase whereby the variant polymerase has reduced affinity for uracil than the wild-type polymerase. Such variant polymerases may be usefully employed in biological assay systems such as the polymerase chain reaction.
    Type: Application
    Filed: April 15, 2003
    Publication date: March 16, 2006
    Applicant: the university of newcastle
    Inventors: Bernard Connolly, Mark Fogg, Laurence Pearl
  • Patent number: 6333183
    Abstract: Polymerases from the Pol I family which are able to efficiently use ddNTPs have demonstrated a much improved performance when used to sequence DNA. A number of mutations have been made to the gene coding for the Pol II family DNA polymerase from the archaeon Pyrococcus furiosus with the aim of improving ddNTP utilisation. “Rational” alterations to amino acids likely to be near the dNTP binding site (based on sequence homologies and structural information) did not yield the desired level of selectivity for ddNTPs. However, alteration at four positions (Q472, A486, L490 and Y497) gave rise to variants which incorporated ddNTPs better than the wild type, allowing sequencing reactions to be carried out at lowered ddNTP:dNTP ratios. Wild type Pfu-Pol required a ddNTP:dNTP ratio of 30:1; values of 5:1 (Q472H), 1:3 (L490Y), 1:5 (A486Y) and 5:1 (Y497A) were found with the four mutants; A486Y representing a 150-fold improvement over the wild type.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: December 25, 2001
    Assignee: Amersham Pharmacia Biotech, Inc.
    Inventors: Steven Evans, Joseph Anthony Mamone, Maria Davis, Bernard A. Connolly